reboxetine has been researched along with epibatidine in 2 studies
Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (epibatidine) | Trials (epibatidine) | Recent Studies (post-2010) (epibatidine) |
---|---|---|---|---|---|
626 | 193 | 184 | 593 | 0 | 115 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arias, HR; Benson, LC; Fedorov, NB; Feuerbach, D; Gatto, GJ; Lippiello, PM; Ortells, MO | 1 |
Arias, HR; Feuerbach, D; Ortells, MO | 1 |
2 other study(ies) available for reboxetine and epibatidine
Article | Year |
---|---|
Functional and structural interaction of (-)-reboxetine with the human α4β2 nicotinic acetylcholine receptor.
Topics: Adrenergic Uptake Inhibitors; Alkaloids; Animals; Azocines; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Dose-Response Relationship, Drug; Electrophysiological Phenomena; Epithelial Cells; HEK293 Cells; Humans; Imipramine; Models, Molecular; Molecular Conformation; Morpholines; Nicotinic Agonists; Patch-Clamp Techniques; Pyridines; Quinolizines; Radioligand Assay; Reboxetine; Receptors, Nicotinic; Torpedo | 2013 |
(-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
Topics: Adrenergic Uptake Inhibitors; Animals; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Humans; Ion Transport; Molecular Docking Simulation; Molecular Dynamics Simulation; Morpholines; Muscle, Skeletal; Pyridines; Radioligand Assay; Reboxetine; Receptors, Nicotinic; Torpedo | 2013 |